Oruka Therapeutics (ORKA) EPS (Basic) (2010 - 2024)
Oruka Therapeutics (ORKA) posted quarterly EPS (Basic) of -$14.95 for Q2 2024, down 1077.54% year-over-year from $1.53 in Q3 2023, and down 157.82% quarter-over-quarter from -$5.8 in Q1 2024.
Powered by 
Analysis
Oruka Therapeutics (ORKA) EPS (Basic) (2010 - 2024) Analysis & Trends
Oruka Therapeutics' EPS (Basic) history runs 15 years deep, the most recent figure standing at -$14.95 for Q2 2024.
- In Q2 2024, EPS (Basic) fell 1077.54% year-over-year to -$14.95; the TTM figure through Mar 2025 stood at -$0.43 (up 95.41% YoY), while the FY2023 annual figure was -$50.67, up 5.36% from the prior year.
- EPS (Basic) for Q2 2024 stood at -$14.95, down from -$5.8 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.93 in Q4 2023, with the low at -$14.95 in Q2 2024.
- The 5-year median for EPS (Basic) is -$3.94 (2020), against an average of -$4.84.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) surged 80.04% in 2022, then plunged 1077.54% in 2024.
- Oruka Therapeutics' EPS (Basic) stood at -$13.36 in 2020, then jumped by 63.33% to -$4.9 in 2021, then soared by 80.04% to -$0.98 in 2022, then climbed by 5.06% to -$0.93 in 2023, then sank by 1511.17% to -$14.95 in 2024.
- Business Quant data shows ORKA's EPS (Basic) at -$14.95 in Q2 2024, -$5.8 in Q1 2024, and -$0.93 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Oruka Therapeutics | 5.82 Bn | 4.09 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -2.22 |
| Mar 31, 2024 | -1.66 |
| Dec 31, 2023 | -0.91 |
| Sep 30, 2023 | -1.19 |
| Jun 30, 2023 | -1.23 |
| Mar 31, 2023 | -1.12 |
| Dec 31, 2022 | -0.98 |
| Sep 30, 2022 | -1.94 |
| Jun 30, 2022 | -2.62 |
| Mar 31, 2022 | -2.72 |
| Dec 31, 2021 | -4.90 |
| Sep 30, 2021 | -3.92 |
| Jun 30, 2021 | -4.03 |
| Mar 31, 2021 | -3.98 |
| Dec 31, 2020 | -7.86 |
| Sep 30, 2020 | -3.95 |
| Jun 30, 2020 | -8.71 |
| Mar 31, 2020 | -9.94 |
| Dec 31, 2019 | -2.20 |
| Sep 30, 2019 | -9.12 |